四川医学2016，Vol.37Issue(4)：444-446,3.DOI:10.16252/j.cnki.issn1004-0501-2016.04.024
基层PCI术后冠心病患者服用抗血小板药物依从性调查分析
Compliance of Antiplatelet After PCI with Grassroots coronary heart Disease
周树军 1王振娟 1张立强 1王云梅 1宗文仓 1孔令军 1娄志刚1
作者信息
- 1. 玉田县医院药剂科，心内科，河北 玉田064100
- 折叠
摘要
Abstract
Objective To evaluate the clinical prognosis of different compliance dual antiplatelt therapy after percutane-ous coronary intervention( PCI) with grassroots coronary heart disease. Methods The study enrolled 180 patients who received drug-eluting stents from 2011 to 2014,Responsible for clinical pharmacists,each patient medications and cardiovascular adverse e-vents detailed record ( death、myocardial infarction、stroke、revascularization ) Occurrence. according to followup antiplatelet drug use,Patients were divided into Continuous treatment group(n=138)and poor compliance group(n=42),Comparison of two groups of major adverse cardiac events( MACE) incidence. Results Baseline characteristics of the two groups of patients,the clinical fea-tures and treatment results and other general information was no significant difference(P>0. 05). Continuous treatment group of major adverse events and readmissions due to cardiovascular events were significantly lower than poor compliance group,the difference was statistically significan(P<0. 05). Conclusion Dual antiplatelet drugs and better compliance can reduce the incidence of cardiovas-cular events,Grassroots coronary heart disease patients after PCI dual antiplatelet medication compliance needs to be improved.关键词
抗血小板药物/经皮冠状动脉介入治疗术/心血管事件/冠心病Key words
antiplatelet drugs/percutaneous coronary intervention/cardiovascular events/coronary heart disease分类
医药卫生引用本文复制引用
周树军,王振娟,张立强,王云梅,宗文仓,孔令军,娄志刚..基层PCI术后冠心病患者服用抗血小板药物依从性调查分析[J].四川医学,2016,37(4):444-446,3.
